Device Trial Radar · NCT07184437
A Clinical Investigation of MINIVISC® PLUS 14 mg/ml Fermented Ophthalmic Viscosurgical Device (OVD-F), Used for Cataract Surgery and Implantation of Intraocular Lenses, Glaucoma Surgery, Anterior Segment Surgery and Corneal Transplantation (CGAC)
Last checked: Nov 20, 2026Latest source record: Sep 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
134
Actual
Start
Feb 20, 2024
Primary completion
Jun 19, 2025
Study completion Jul 29, 2025
Sponsor
- Lead sponsor
- Bohus Biotech ABNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Key2Compliance
- First posted
- Sep 19, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A clinical investigation to confirm the clinical safety and performance of OVD-F device MINIVISC® PLUS 1.4 % for cataract surgery and implantation of intraocular lenses, glaucoma surgery, anterior segment surgery and corneal transplantation.
Conditions
- Cataract
Interventions
OVD-F device Minivisc®PLUS 14 mg/mlDevice
MINIVISC® PLUS 14 mg/ml is intended to protect, lubricate and support delicate ophthalmic cells or tissues, to assist in maintaining intraocular space and to enhance visualization during surgery.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary efficacy endpoint is the postoperative intraocular pressure (IOP)Time frame: 7 days
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
UZ Leuven
Leuven, Belgium
Eye Clinic Falu Hosptal
Falun, Dalarna County, Sweden
Opthalmic Clinic University Hospital Linköping
Linköping, Östergötland County, Sweden
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.